pipette
ENEnglish

Timing of First Poststroke Seizure and Risk of Seizure Recurrence by Stroke Subtype

K. M. Schubert, I. Berg, M. E. Pedrazzetti, L. Delazer, E. Lindgren, N. Orlandi, S. Meletti, L. Abraira, D. Campos-Fernandez, K. Fukuma, M. Ihara, V. Dasari, V. Punia, B. Landau, P. Lochner, Y. Winter, P.-E. Tsalouchidou, Y. Wang, G. Merlino, M. Valente, C. Bentes, M. Alet, A. C. G. Franco, A. L. Oliveira, C. S. Khoo, R. Helbok, J. Gruber, V. K. Kimiskidis, J. I. Doerrfuss, V. Leclercq, N. Gaspard, M. R. Heldner, J. Putaala, D. Aguiar de Sousa, J. M. Coutinho, M. P. Zafra-Sierra, L. C. Mayor-Romero, M. R. Keezer, A. Pezzini, R. P. W. Rouhl, J. S. Duncan

PreprintUso en el mundo real

En palabras de los autores

Importance: The 7-day cutoff separating acute symptomatic from unprovoked poststroke seizures guides epilepsy diagnosis and long-term antiseizure medication but is consensus based and unvalidated against recurrence risk by stroke subtype. Objective: To determine whether seizure recurrence risk changes abruptly at day 7 and how it varies with first-seizure timing by stroke subtype. Design, Setting, and Participants: This pooled analysis of individual participant data from 36 cohorts in 22 countries (inclusion, 1994-2025) included adults with a first seizure after ischemic stroke, intracerebral hemorrhage, aneurysmal subarachnoid hemorrhage, or cerebral venous thrombosis. Exposure: Days from stroke onset (or venous thrombosis diagnosis) to first seizure. Main Outcomes and Measures: The 10-year cumulative incidence of unprovoked seizure recurrence, with death as a competing event, from stabilized inverse probability of treatment-weighted Fine-Gray spline models. Risk zones were based on the likelihood of being helped vs harmed and the 60% epilepsy threshold of the International League Against Epilepsy. Results: Of 2434 individuals (median [IQR] age, 63 [49-75] years; 1181 [48.5%] female), 684 (28.1%) had a seizure recurrence. Risk changed gradually with first-seizure timing, without a day-7 transition; overall 10-year risk differed by subtype (cerebral venous thrombosis, 44%; intracerebral hemorrhage, 43%; ischemic stroke, 40%; subarachnoid hemorrhage, 35%; P < .001). At day 7, the 10-year risk was 24% (95% CI, 17%-32%) after ischemic stroke, 30% (95% CI, 22%-38%) after intracerebral hemorrhage, 41% (95% CI, 22%-53%) after subarachnoid hemorrhage, and 58% (95% CI, 44%-71%) after cerebral venous thrombosis. The 60% threshold was crossed from day 71 after ischemic stroke, day 41 after intracerebral hemorrhage, and day 9 after cerebral venous thrombosis; after subarachnoid hemorrhage, only seizures on days 2 to 3 exceeded it. Mortality was inversely related to recurrence risk. Of 800 first seizures after day 7 following ischemic stroke or intracerebral hemorrhage, which would qualify as epilepsy under current criteria, 335 (42%) had a recurrence risk below the 60% diagnostic threshold. Conclusions and Relevance: In this pooled analysis, seizure recurrence risk after stroke rose gradually, not abruptly at day 7, and differed by subtype. After external validation, subtype-specific risk zones could inform individualized decisions about long-term antiseizure medication.

Resultado principalEl resumen no menciona limitaciones.

Apareció: martes, 17 de noviembre. medRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.11.13.26368030